MentionFox
Home › Layoffs › Athira Pharma, Inc.
SEC filings · Form 8-K, Item 2.05

Athira Pharma, Inc. layoffs and restructuring

Before you join, sell to or invest in Athira Pharma, Inc.

MentionFox check on Athira Pharma, Inc.: only 1 source on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/athira-pharma

  • Note: Layoff plan disclosed Sep 2024 (about 49 employees) (filing)

New since last check: Layoff plan disclosed Sep 2024 (about 49 employees) (filing, first seen 14 November 2026).

Check Athira Pharma, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Athira Pharma, Inc.?

Every exit or restructuring plan Athira Pharma, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 49 employees are affected, about 70% of its workforce, according to Athira Pharma, Inc.'s latest layoff filing, on September 17, 2024. As of November 15, 2026, Athira Pharma, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, September 17, 2024).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Oliveira Steven Michael also filed stake reports on 1 other company ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Athira Pharma, Inc.

Free to see. No signup.

People from Athira Pharma, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Athira Pharma, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest, employees49
Latest filing2024-09-17

Athira Pharma, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Athira Pharma have layoffs in 2024? What its filings say

Athira Pharma, Inc. (CIK 1620463) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2024-09-17

Employees affected

On September 15, 2024, Athira Pharma, Inc. (the "Company") committed to a workforce reduction that is expected to result in the termination of approximately 49 positions, representing approximately 70% of the Company's workforce (the "Restructuring").

Expected charges

In connection with the Restructuring, the Company currently estimates it will incur one-time costs of approximately $2.8 million, consisting primarily of cash severance costs and termination benefits, which the Company expects to recognize in the third quarter of 2024.

Timing

The Company expects to substantially complete the Restructuring by December 31, 2024.

Also on the record for Athira Pharma, Inc.

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G, by Spruce Street Capital LP4.2% of the class5%+ stakesSource
November 4, 2026Stake report, Schedule 13G, by Great Point Partners, LLC5.03% of the class5%+ stakesSource
October 28, 2026Stake report, Schedule 13D/A, by Sermonix Pharmaceuticals, Inc.25.1% of the class5%+ stakesSource
October 26, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource
August 31, 2026Stake report, Schedule 13D, by Sermonix Pharmaceuticals, Inc.36.9% of the class5%+ stakesSource
August 25, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource
August 20, 2026Stake report, Schedule 13G/A, by Anders Hove12.1% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G, by ADAR1 Capital Management, LLC7.7% of the class5%+ stakesSource
May 7, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource
March 19, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
February 6, 2026Stake report, Schedule 13G/A, by Baselake Partners, LP1.9% of the class5%+ stakesSource
January 16, 2026Stake report, Schedule 13D/A, by Perceptive Advisors LLC19.99% of the class5%+ stakesSource

Keep reading

More on Athira Pharma, Inc. and the records around it.

Athira Pharma, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Athira Pharma, Inc.?

Want the whole picture on Athira Pharma, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Athira Pharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Athira Pharma, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 19 records.

Tools for this story

Each opens in a new tab, filled in for Athira Pharma, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/athira-pharma
Last updated 2026-11-15
Athira Pharma, Inc. layoffs 2024: about 49 jobs (8-K). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/athira-pharma